67 related articles for article (PubMed ID: 9026851)
21. [Effectiveness analysis of HA based triple-drug regimen as induction chemotherapy in the treatment of acute myeloid leukemia and its relationship with karyotype].
Mi YC; Xue YP; Yu WJ; Liu SH; Zhao YZ; Meng QX; Bian SG; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):705-9. PubMed ID: 16620570
[TBL] [Abstract][Full Text] [Related]
22. [Current therapeutic strategies in the management of acute myeloid leukemia].
Fiegl M; Hiddemann W; Braess J
Med Klin (Munich); 2007 Apr; 102(4):309-16. PubMed ID: 17426934
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors for patients with acute myeloid leukaemia or high-risk myelodysplastic syndromes undergoing myeloablative or non-myeloablative allogeneic blood stem cell transplantation.
Graef T; Vaupel M; Fenk R; Ruf L; Zohren F; Germing U; Haas R; Kobbe G
Hematol Oncol; 2007 Dec; 25(4):170-7. PubMed ID: 17579887
[TBL] [Abstract][Full Text] [Related]
24. Disease biology rather than age is the most important determinant of survival of patients > or = 60 years with acute myeloid leukemia treated with uniform intensive therapy.
Gupta V; Chun K; Yi QL; Minden M; Schuh A; Wells R; Brandwein J
Cancer; 2005 May; 103(10):2082-90. PubMed ID: 15830348
[TBL] [Abstract][Full Text] [Related]
25. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.
Bloomfield CD; Lawrence D; Byrd JC; Carroll A; Pettenati MJ; Tantravahi R; Patil SR; Davey FR; Berg DT; Schiffer CA; Arthur DC; Mayer RJ
Cancer Res; 1998 Sep; 58(18):4173-9. PubMed ID: 9751631
[TBL] [Abstract][Full Text] [Related]
26. The prognostic significance of leukemic cells clearance kinetics evaluation during the initial course of induction therapy with HAD (homoharringtonine, cytosine arabinoside, daunorubicin) in patients with de novo acute myeloid leukemia.
Xiao Z; Xue H; Li R; Zhang L; Yu M; Hao Y
Am J Hematol; 2008 Mar; 83(3):203-5. PubMed ID: 17874451
[TBL] [Abstract][Full Text] [Related]
27. [Analysis of prognostic factors in patients with refractory acute myeloid leukemia].
Zhang Q; Feng R; Liu QF; Liu XL; Xu B; Zheng WY; Meng FY; Zhou SY
Di Yi Jun Yi Da Xue Xue Bao; 2003 Sep; 23(9):934-6. PubMed ID: 13129725
[TBL] [Abstract][Full Text] [Related]
28. Case-control study of multidrug resistance phenotype and response to induction treatment including or not fludarabine in newly diagnosed acute myeloid leukaemia patients.
Malagola M; Damiani D; Martinelli G; Michelutti A; Cesana B; Vivo AD; Piccaluga PP; Ottaviani E; Candoni A; Geromin A; Tiribelli M; Fanin R; Testoni N; Lauria F; Bocchia M; Gobbi M; Pierri I; Zaccaria A; Zuffa E; Mazza P; Priccolo G; Gugliotta L; Bonini A; Visani G; Skert C; Bergonzi C; Roccaro AM; Filí C; Baccarani M; Russo D
Br J Haematol; 2007 Jan; 136(1):87-95. PubMed ID: 17222198
[TBL] [Abstract][Full Text] [Related]
29. Day 14 bone marrow biopsy in predicting complete remission and survival in acute myeloid leukemia.
Hussein K; Jahagirdar B; Gupta P; Burns L; Larsen K; Weisdorf D
Am J Hematol; 2008 Jun; 83(6):446-50. PubMed ID: 18247382
[TBL] [Abstract][Full Text] [Related]
30. Bcl-2 expression in acute myelogenous leukemia: the relation to myeloid antigen expression and response to therapy in Iranian patients.
Daneshbod Y; Amirghofran Z; Tabei SZ
Neoplasma; 2005; 52(2):109-14. PubMed ID: 15800708
[TBL] [Abstract][Full Text] [Related]
31. Persistence of peripheral blood and bone marrow blasts during remission induction in adult acute lymphoblastic leukemia confers a poor prognosis depending on treatment intensity.
Cortes J; Fayad L; O'Brien S; Keating M; Kantarjian H
Clin Cancer Res; 1999 Sep; 5(9):2491-7. PubMed ID: 10499624
[TBL] [Abstract][Full Text] [Related]
32. FLT3 mutations in normal karyotype acute myeloid leukemia in first complete remission treated with autologous peripheral blood stem cell transplantation.
Yoshimoto G; Nagafuji K; Miyamoto T; Kinukawa N; Takase K; Eto T; Kato K; Hayashi S; Kamimura T; Ohno Y; Taniguchi S; Harada M
Bone Marrow Transplant; 2005 Dec; 36(11):977-83. PubMed ID: 16184177
[TBL] [Abstract][Full Text] [Related]
33. The expression of CD 15 antigen on myeloid leukaemia cells--a new prognostic index for complete remission and for survival.
Hołowiecki J; Lutz D; Krzemień S; Schranz V; Jagoda K; Hołowiecka B; Graf F; Kelenyi G; Callea V; Brugiatelli M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(2):289-95. PubMed ID: 2475410
[TBL] [Abstract][Full Text] [Related]
34. [Prognostic importance of DNA histograms of bone marrow cells in acute myeloblastic leukemias].
Janowska-Wieczorek A; Maj S; Apel D
Acta Haematol Pol; 1981; 12(3-4):171-4. PubMed ID: 6952737
[TBL] [Abstract][Full Text] [Related]
35. Acute nonlymphoid leukemia.
Necheles TF
Pediatr Ann; 1978 Jul; 7(7):483-90. PubMed ID: 353670
[TBL] [Abstract][Full Text] [Related]
36. [Manifestations, treatment and prognosis in acute leukemia].
Petrov M; Georgieva V; Velizarova K; Georgiev G; Peĭchev D
Vutr Boles; 1982; 21(5):96-103. PubMed ID: 6962574
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of DNA histograms of bone marrow cells in acute myeloblastic leukaemias.
Maj S; Janowska-Wieczorek A; Apel D
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(2):186-9. PubMed ID: 6208101
[TBL] [Abstract][Full Text] [Related]
38. New progressive factors affecting response and survival in adult acute leukemia.
Freireich EJ; Gehan EA; Bodey GP; Hersh EM; Hart JS; Gutterman JU; McCredie KB
Trans Assoc Am Physicians; 1974; 87():298-305. PubMed ID: 4617371
[No Abstract] [Full Text] [Related]
39. [The prognostic significance of parameters of bone marrow blast cell proliferation in patients with acute leukemia].
Kotel'nikov VM; Abakumov EM; Isaev VG; Morozova NG; Timkina EN
Gematol Transfuziol; 1989 Nov; 34(11):14-8. PubMed ID: 2612858
[TBL] [Abstract][Full Text] [Related]
40. The prognostic value of cytogenetic analyses in patients with acute nonlymphocytic leukemia treated with the same intensive chemotherapy.
Tashiro S; Kyo T; Tanaka K; Oguma N; Hashimoto T; Dohy H; Kamada N
Cancer; 1992 Dec; 70(12):2809-15. PubMed ID: 1451059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
